Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ERG Immunohistochemistry and Clinicopathologic Characteristics in Korean Prostate Adenocarcinoma Patients

´ëÇѺ´¸®ÇÐȸÁö 2012³â 46±Ç 5È£ p.423 ~ 428
Suh Ja-Hee, Park Jeong-Whan, ÀÌö, ¹®°æö,
¼Ò¼Ó »ó¼¼Á¤º¸
 ( Suh Ja-Hee ) 
Seoul National University College of Medicine Department of Pathology

 ( Park Jeong-Whan ) 
Seoul National University College of Medicine Department of Pathology
ÀÌö ( Lee Cheol ) 
Seoul National University College of Medicine Department of Pathology
¹®°æö ( Moon Kyung-Chul ) 
Seoul National University College of Medicine Department of Pathology

Abstract


Background : Transmembrane protease serine 2-ETS related gene (TMPRSS2-ERG) gene fusion, the most common genetic alternation in prostate cancer, is associated with protein expression of the oncogene ERG. Recently, an immunohistochemical staining method using an anti-ERG antibody was shown to have a strong correlation with altered ERG protein expression.

Methods : We analyzed a total of 303 radical prostatectomy specimens (obtained from Korean prostate cancer cases) using a constructed tissue microarray and ERG immunohistochemical staining. Thereafter, we evaluated the association between ERG expression and clinicopathological factors.

Results : The ERG-positive rate was 24.4% (74/303) and significantly higher ERG expression was observed in the subgroup with a lower Gleason score (p=0.004). Analysis of the histologic pattern of prostate adenocarcinomas revealed that tumors with discrete glandular units (Gleason pattern 3) displayed higher frequency of ERG expression (p=0.016). The ERG-positive rate was lower than that found (approximately 50%) in studies involving western populations. Other factors including age, tumor volume, initial protein-specific antigen level, a pathological stage and margin status were not significantly related with the ERG expression.

Conclusions : ERG immunohistochemical staining is significantly higher in tumors with well-formed glands and is associated with a lower Gleason score.

Å°¿öµå

Prostate neoplasms; ERG; Immunohistochemistry

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS